Zarraga Julie 4
4 · LanzaTech Global, Inc. · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Zarraga Julie
EVP, Engineering
Transactions
- Award
Stock Options
2023-02-08+20,000→ 20,000 totalExercise: $1.52Exp: 2025-09-28→ Common Stock (87,493 underlying) - Award
Stock Options
2023-02-08+20,000→ 20,000 totalExercise: $1.52Exp: 2026-02-12→ Common Stock (87,493 underlying) - Award
Stock Options
2023-02-08+20,000→ 20,000 totalExercise: $1.38Exp: 2026-10-13→ Common Stock (87,493 underlying) - Award
Stock Options
2023-02-08+30,000→ 30,000 totalExercise: $1.07Exp: 2030-06-26→ Common Stock (131,240 underlying)
Footnotes (3)
- [F1]Options are fully vested and exercisable.
- [F2]60% of the options are vested and exercisable, 20% vests on each of January 1, 2024 and January 1, 2025.
- [F3]On February 8, 2023, AMCI Acquisition Corp. II ("AMCI") consummated a business combination (the "Business Combination") by and among AMCI, AMCI Merger Sub, Inc., a Delaware corporation ("AMCI Merger Sub") and LanzaTech NZ, Inc., a Delaware corporation ("Legacy LanzaTech"), AMCI changed its name to "LanzaTech Global, Inc." and AMCI Merger Sub merged with and into Legacy LanzaTech. As part of the Business Combination, each Legacy LanzaTech stock option was exchanged for a stock option to acquire 4.374677 shares of common stock of LanzaTech Global, Inc.